BIORESTORATIVE THERAPIES, INC. (BRTX)

0.20 -3.35% (-0.01)

Over 3Y: -91.8%

2026-08-28
Style
Area Line Line with markersneeds a shorter window Steps Candlesneeds a shorter window Hollow candlesneeds a shorter window Barsneeds a shorter window

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

1 2 3
2023 2024 2025 2026

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q2 '21 — Revenue: 15K Q2 '21 — Operating Cash Flow: -741.8K Q2 '21 — Net Income: -4.1M Q3 '21 — Revenue: 8K Q3 '21 — Operating Cash Flow: -629.4K Q3 '21 — Net Income: -4.2M Q4 '21 — Revenue: 5K Q4 '21 — Operating Cash Flow: -1.1M Q4 '21 — Net Income: -20.4M Q1 '22 — Revenue: 16K Q1 '22 — Operating Cash Flow: -1.6M Q1 '22 — Free Cash Flow: -1.7M Q1 '22 — Net Income: -4.8M Q2 '22 — Revenue: 71.1K Q2 '22 — Operating Cash Flow: -1.3M Q2 '22 — Free Cash Flow: -1.4M Q2 '22 — Net Income: -4.7M Q3 '22 — Revenue: 29K Q3 '22 — Operating Cash Flow: -1.5M Q3 '22 — Free Cash Flow: -1.5M Q3 '22 — Net Income: -4.7M Q4 '22 — Revenue: 3.7K Q4 '22 — Operating Cash Flow: -1.6M Q4 '22 — Free Cash Flow: -1.7M Q4 '22 — Net Income: -2.7M Q1 '23 — Revenue: 31.3K Q1 '23 — Operating Cash Flow: -2.4M Q1 '23 — Free Cash Flow: -2.4M Q1 '23 — Net Income: -7.2M Q2 '23 — Revenue: 64.5K Q2 '23 — Operating Cash Flow: -1.1M Q2 '23 — Free Cash Flow: -1.2M Q2 '23 — Net Income: -5.7M Q3 '23 — Revenue: 30.7K Q3 '23 — Operating Cash Flow: -1.2M Q3 '23 — Free Cash Flow: -1.2M Q3 '23 — Net Income: 4.8M Q4 '23 — Revenue: 19.3K Q4 '23 — Operating Cash Flow: -1.8M Q4 '23 — Free Cash Flow: -1.8M Q4 '23 — Net Income: -2.3M Q1 '24 — Revenue: 35K Q1 '24 — Operating Cash Flow: -2.3M Q1 '24 — Net Income: -2.2M Q2 '24 — Revenue: 89.1K Q2 '24 — Operating Cash Flow: -1.9M Q2 '24 — Net Income: -4M Q3 '24 — Revenue: 233.6K Q3 '24 — Operating Cash Flow: -1.7M Q3 '24 — Free Cash Flow: -1.8M Q3 '24 — Net Income: -1.1M Q4 '24 — Revenue: 43.3K Q4 '24 — Operating Cash Flow: -2.3M Q4 '24 — Free Cash Flow: -2.4M Q4 '24 — Net Income: -1.6M Q1 '25 — Revenue: 25K Q1 '25 — Operating Cash Flow: -2.8M Q1 '25 — Free Cash Flow: -2.8M Q1 '25 — Net Income: -5.3M Q2 '25 — Revenue: 303.3K Q2 '25 — Operating Cash Flow: -2.7M Q2 '25 — Free Cash Flow: -2.7M Q2 '25 — Net Income: -2.7M Q3 '25 — Revenue: 11.8K Q3 '25 — Operating Cash Flow: -2.9M Q3 '25 — Free Cash Flow: -2.9M Q3 '25 — Net Income: -3M Q4 '25 — Revenue: 19.6K Q4 '25 — Operating Cash Flow: -2.4M Q4 '25 — Free Cash Flow: -2.5M Q4 '25 — Net Income: -3.2M Q1 '26 — Revenue: 23.2K Q1 '26 — Operating Cash Flow: -3.8M Q1 '26 — Net Income: -2.2M -18M -12M -6M 0 6M
Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-03-31, reported in USD. The newest fact in the filings is dated 2026-03-31, 152 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

1.0
SBC / sales 449.0%
Gross margin 92.1%
Accruals 16.4%
Asset turnover 0.077×
ROA -238.3%
ROCE -470.2%
ROE -365.4%
EBITDA margin —
FCF margin —
OCF / EBIT —
OCF margin —
OE margin —
Oper. margin —
Profit margin —
ROIC —

1 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

4.4
RPO / sales 0.42×
RPO growth —
Segment HHI —

4 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

6.1
ND/EBITDA —
Cash runway 0.3 yr
Debt / Eq 0.0×
Debt payback 0.0 yr
Quick ratio 2.4×
F-score 3.4 pts
Cash / Debt —
Interest cover —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

5.4
Sales CAGR 4Y +67.2%
Sales/sh Y/Y -21.0%
Sales Q/Q -7.3%
Shares change +15.8%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.